What is the Scope for Biotechs in Precision Medicine?

StartUp City | Monday, April 26, 2021

This current world holds great promise for biotech companies in terms of creativity – new drug targets, newly developed medicines, new drug delivery systems, and engineered cell or gene therapies, to name a few.

Fremont, CA: Precision medicine has evolved dramatically over the last two decades. The completion of the first human genome project signaled the start of a new era of knowledge, resulting in exciting discoveries that enhanced our understanding of disease genetics and contributed to the discovery of new drug targets. The project was a driving force behind today's modernized clinical trials, which make use of a vast amount of previously unavailable molecular data. Precision medicine has been modeled after this.

Precision medicine has influenced not only drug development but also drug discovery and disease diagnosis, enabling scientists to identify diseases using molecular features rather than clinical signs and symptoms.

Getting New scientific Insights through Data Analysis

The paradigm is clearly moving away from a one-size-fits-all approach to a far more in-depth understanding of the biology, disease, and genome for a given disease. Understanding the molecular basis of disease helps one to repurpose a medication from one disease to many diseases, increasing its value.

The rate of innovation is picking up. Different types of biomarkers are beginning to be integrated into clinical development to better understand variance in clinical response. Scientists may gain valuable insights into why patients have responded in various ways by overlaying biomarker data onto clinical trial data. Global regulatory agencies support precision medicine and are increasingly requesting that companies use biomarker data to understand variance in clinical response.

This current world holds great promise for biotech companies in terms of creativity – new drug targets, newly developed medicines, new drug delivery systems, and engineered cell or gene therapies, to name a few.

Biotech firms are also more agile and versatile than their large-pharma rivals, giving them a competitive edge. Indeed, biotech is developing some of the most important and groundbreaking new treatments for rare and untreated diseases.

One of the main benefits of precision medicine-guided drug production is that it allows drug developers to produce important data to show payers that the medicine will perform well for a specific group of patients. This will aid reimbursement and provide not only patients with a valuable new drug but also value to the business.

See Also:Top BioTech Startups

Weekly Brief